Vivid Seats Inc. Class A SEAT 深 滬
已收盤 05-08 16:00:00 美东时间
9.01
+0.040
+0.45%
華盛通- 最 高9.50
- 今 開8.87
- 成交量 14.94万股
- 最 低 8.49
- 昨 收 8.97
- 總市值 9899.66万
- 52周最高 41.20
- 市盈率 靜 --
- 換手率 1.36%
- 52周最低 5.06
- 委 比 24.69%
- 總股本 1098.74万
- 歷史最高 287.00
- 量 比 0.87
- 振 幅 11.26%
- 歷史最低 5.06
- 每 手 1
- 風險率 11.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Vivid Seats Reports Q1 2026 Results: Full Earnings Call Transcript
On Tuesday, Vivid Seats (NASDAQ:SEAT) discussed first-quarter financial results...
05-05 21:34
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
Vivid Seats Q1 EPS $(1.35) Misses $(1.11) Estimate
Vivid Seats (NASDAQ:SEAT) reported quarterly losses of $(1.35) per share which missed the analyst consensus estimate of $(1.11) by 21.62 percent. This is a 35 percent decrease over losses of $(1.00) per share from the
05-05 18:45
Vivid Seats Q1 Sales $125.783M Beat $125.097M Estimate; Net Loss $14.63M Up From $5.94M YoY
Vivid Seats (NASDAQ:SEAT) reported quarterly sales of $125.783 million which beat the analyst consensus estimate of $125.097 million by 0.55 percent. This is a 23.31 percent decrease over sales of $164.023 million the
05-05 18:32
Elizabeth Warren Calls Ticketmaster Verdict A 'Huge Win' For Music Fans, Slams Trump DOJ For Giving Company A 'Measly Slap…'
Elizabeth Warren and others celebrated after a jury found Ticketmaster and Live Nation Entertainment ran an illegal monopoly.
04-16 10:53
Ticketmaster, Live Nation Has Illegal Monopoly Over Concert Venues, Jury Finds
Jury finds that Live Nation and Ticketmaster operated an illegal monopoly over major concert venues.
04-16 05:00
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
Vivid Seats Analysts Cut Their Forecasts After Q4 Loss
Vivid Seats (NASDAQ:SEAT) reports Q4 loss of $428.7M, revenue down 37% to $126.8M. Shares up 4.4% to $5.90. Analysts adjust price targets.
03-14 17:18
Benchmark Maintains Buy on Vivid Seats, Lowers Price Target to $10
Benchmark analyst Daniel L. Kurnos maintains Vivid Seats (NASDAQ:SEAT) with a Buy and lowers the price target from $18 to $10.
03-13 20:45
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
